Hot topics close

Fewer treatment options? Multidrug resistance and the challenge of controlling Acinetobacter baumannii in Latvian hospitals

Fewer treatment options Multidrug resistance and the challenge of 
controlling Acinetobacter baumannii in Latvian hospitals
Acinetobacter baumannii is a bacterium that can cause a variety of infections associated with medical settings, as this is where infections are most commonly contracted. In 2022, Latvia still had one of the highest levels of resistance to Acinetobacter ba

Acinetobacter baumannii is a bacterium that can cause a variety of infections associated with medical settings, as this is where infections are most commonly contracted.

In 2022, Latvia still had one of the highest levels of resistance to Acinetobacter baumannii: 63.3% of Acinetobacter spp. samples were resistant to fluoroquinolones, aminoglycosides and carbapenems, which are antibiotics used to treat bacterial infections.

slimnica_shutterstock00.jpgPatient in hospital. Photo: Shutterstock

In his 2014 review of antimicrobial resistance, which occurs when bacteria, viruses or other micro-organisms become resistant to drugs, British economist Jim O'Neill predicted that unless strong action is taken, 10 million people worldwide could die each year from infections caused by resistant micro-organisms by 2050. This would exceed the current global death toll from cancer.

In the latest World Health Organisation report, the World Bank estimates that antimicrobial resistance could cost up to 3.8% of global GDP by 2050. Joint replacement, caesarean section, chemotherapy and various types of transplantation are among the treatments that depend on affordable and effective antimicrobials. Without them—and in the face of widespread antimicrobial resistance—many of these treatments could become riskier or even impossible.

Māris Liepiņš' doctoral thesis explores how long Acinetobacter baumannii remains in the body after infection. This information is crucial for determining the optimal timing for preventing and controlling the spread of the infection.

The results of the study provide a scientific basis for the development of strategies to improve infection control.

The defence of Māris Liepiņš's doctoral thesis, titled ‘Duration of carriage of multidrug-resistant Acinetobacter baumannii and its impact on infection control measures and antimicrobial use’, will take place on 12 November.

For more information, visit the event's page.

RSU dissertation catalogue

Similar news
News Archive
  • Darbar
    Darbar
    Darbar Box Office Collection Day 1: Rajnikanth-starrer earns Rs 2 crore in Chennai
    8 Jan 2020
    19
  • Systems integrator
    Systems integrator
    Blockchain in Fintech Market – Global Briefing, Growth Analysis And Opportunities Outlook 2020 To 2026
    24 Jun 2023
    1
  • Seri Duta 1 Condo
    Seri Duta 1 Condo
    DBKL: Seri Duta 1 Condo building unsafe; critical landslide risk
    27 Dec 2021
    1
  • Tesla Model 3
    Tesla Model 3
    Tesla increases Model 3 Performance price in the U.S.
    20 May 2024
    18
  • Dietary fiber
    Dietary fiber
    Expert warns of nutritional deficiency that could put you at risk of major health problems
    4 Feb 2024
    7
  • Redmi Note 13
    Redmi Note 13
    Redmi Note 13 Hands On: The Base Of A Confusing Range ...
    15 Jan 2024
    1
This week's most popular news